In July 2015, he was one of the first patients to undergo a radical, not - yet - FDA - approved, minimally invasive surgical procedure at the West Virginia University hospital with a device called a WEB
Aneurysm Embolization System.
Robert Morgan's clinical interests are the imaging and the endovascular treatment of aortic and peripheral vascular disease;
embolization of haemorrhage, visceral artery
aneurysms and endoleaks; and hemodialysis access management including the percutaneous creation of arteriovenous fistulas.